[go: up one dir, main page]

DK408289D0 - Diagnostisk reagens - Google Patents

Diagnostisk reagens

Info

Publication number
DK408289D0
DK408289D0 DK408289A DK408289A DK408289D0 DK 408289 D0 DK408289 D0 DK 408289D0 DK 408289 A DK408289 A DK 408289A DK 408289 A DK408289 A DK 408289A DK 408289 D0 DK408289 D0 DK 408289D0
Authority
DK
Denmark
Prior art keywords
antibody
fibrinolytic enzyme
fibrinolytic
increased
vivo
Prior art date
Application number
DK408289A
Other languages
English (en)
Inventor
Johan Selmer
Niels Tromholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK408289A priority Critical patent/DK408289D0/da
Publication of DK408289D0 publication Critical patent/DK408289D0/da
Priority to AT90912800T priority patent/ATE92770T1/de
Priority to DE90912800T priority patent/DE69002769T2/de
Priority to AU62859/90A priority patent/AU639940B2/en
Priority to PCT/DK1990/000210 priority patent/WO1991002546A1/en
Priority to CA002065147A priority patent/CA2065147A1/en
Priority to DK90912800.1T priority patent/DK0487594T3/da
Priority to ES90912800T priority patent/ES2058931T3/es
Priority to EP90912800A priority patent/EP0487594B1/en
Priority to NZ234937A priority patent/NZ234937A/xx
Priority to JP2512113A priority patent/JPH04507254A/ja
Priority to FI920669A priority patent/FI920669A7/fi
Priority to DD90343498A priority patent/DD297064A5/de
Priority to KR1019920700340A priority patent/KR920703120A/ko
Priority to CS904047A priority patent/CZ280904B6/cs
Priority to IL9540790A priority patent/IL95407A/en
Priority to US07/569,127 priority patent/US5165912A/en
Priority to IE297790A priority patent/IE65525B1/en
Priority to NO92920624A priority patent/NO920624L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK408289A 1989-08-18 1989-08-18 Diagnostisk reagens DK408289D0 (da)

Priority Applications (19)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
KR1019920700340A KR920703120A (ko) 1989-08-18 1990-08-16 선유소 용해 활성 검출 시약
EP90912800A EP0487594B1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
JP2512113A JPH04507254A (ja) 1989-08-18 1990-08-16 線維素溶解活性検出用試薬
AU62859/90A AU639940B2 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
PCT/DK1990/000210 WO1991002546A1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity
CA002065147A CA2065147A1 (en) 1989-08-18 1990-08-16 Reagent for the detection of fibrinolytic activity
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet
ES90912800T ES2058931T3 (es) 1989-08-18 1990-08-16 Un reactivo para la deteccion de actividad fibrinolitica.
AT90912800T ATE92770T1 (de) 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung.
NZ234937A NZ234937A (en) 1989-08-18 1990-08-16 Diagnostic reagent comprising a labelled antibody against a fibrinolytic enzyme and its use in detection of an enzyme associated with thromboses
DE90912800T DE69002769T2 (de) 1989-08-18 1990-08-16 Mittel zum nachweis einer fibrinolytischen wirkung.
FI920669A FI920669A7 (fi) 1989-08-18 1990-08-16 Reagenssi fibrinolyyttisen aktiivisuuden havaitsemiseksi
DD90343498A DD297064A5 (de) 1989-08-18 1990-08-16 Reagens zum nachweis der fibrinolytischen aktivitaet
IE297790A IE65525B1 (en) 1989-08-18 1990-08-17 A reagent for the detection of fibrinolytic activity
CS904047A CZ280904B6 (cs) 1989-08-18 1990-08-17 Diagnostické činidlo pro detekci zvýšené hladiny fibrinolytického enzymu
IL9540790A IL95407A (en) 1989-08-18 1990-08-17 Reagent, composition and method for the detection of fibrinolytic activity
US07/569,127 US5165912A (en) 1989-08-18 1990-08-17 Method for the detection of fibrinolytic activity
NO92920624A NO920624L (no) 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens

Publications (1)

Publication Number Publication Date
DK408289D0 true DK408289D0 (da) 1989-08-18

Family

ID=8129992

Family Applications (2)

Application Number Title Priority Date Filing Date
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90912800.1T DK0487594T3 (da) 1989-08-18 1990-08-16 Reagens til detektion af fibrinolytisk aktivitet

Country Status (18)

Country Link
US (1) US5165912A (da)
EP (1) EP0487594B1 (da)
JP (1) JPH04507254A (da)
KR (1) KR920703120A (da)
AT (1) ATE92770T1 (da)
AU (1) AU639940B2 (da)
CA (1) CA2065147A1 (da)
CZ (1) CZ280904B6 (da)
DD (1) DD297064A5 (da)
DE (1) DE69002769T2 (da)
DK (2) DK408289D0 (da)
ES (1) ES2058931T3 (da)
FI (1) FI920669A7 (da)
IE (1) IE65525B1 (da)
IL (1) IL95407A (da)
NO (1) NO920624L (da)
NZ (1) NZ234937A (da)
WO (1) WO1991002546A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
NZ589557A (en) * 2008-06-04 2012-08-31 Talecris Biotherapeutics Inc Immobilised streptokinase, method and kit for preparing plasmin
EP2403865B9 (en) 2009-03-03 2015-12-09 Grifols Therapeutics Inc. Methods for preparing plasminogen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501321A (ja) * 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (en) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection of vascular disease

Also Published As

Publication number Publication date
NZ234937A (en) 1991-11-26
AU6285990A (en) 1991-04-03
CZ404790A3 (en) 1996-01-17
US5165912A (en) 1992-11-24
NO920624D0 (no) 1992-02-17
KR920703120A (ko) 1992-12-17
IL95407A (en) 1994-07-31
FI920669A0 (fi) 1992-02-17
ATE92770T1 (de) 1993-08-15
IL95407A0 (en) 1991-06-30
IE65525B1 (en) 1995-11-01
EP0487594A1 (en) 1992-06-03
DE69002769D1 (de) 1993-09-16
DE69002769T2 (de) 1993-12-02
ES2058931T3 (es) 1994-11-01
IE902977A1 (en) 1991-02-27
DD297064A5 (de) 1992-01-02
FI920669A7 (fi) 1992-02-17
CZ280904B6 (cs) 1996-05-15
WO1991002546A1 (en) 1991-03-07
DK0487594T3 (da) 1994-01-03
EP0487594B1 (en) 1993-08-11
CA2065147A1 (en) 1991-02-19
NO920624L (no) 1992-02-17
AU639940B2 (en) 1993-08-12
JPH04507254A (ja) 1992-12-17

Similar Documents

Publication Publication Date Title
AU629903B2 (en) Mitomycin c derivatized with a hapten
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
ATE162403T1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
NO904001L (no) Fremgangsmaate og apparat, for diagnostisk analyse.
ATE348843T1 (de) Nachweis von tsh-rezeptor-autoantikörpern mit affinitätsgereinigten antikörpern
EP0259857A3 (en) Method of assaying physiologically active substances
ATE260931T1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
DK408289D0 (da) Diagnostisk reagens
SE7903821L (sv) Kinetisk metning av glykoskoncentrationen i kroppsvetskor och beredning herfor
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE3478958D1 (en) Protein conjugates of penicilloic acid, their preparation and use
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
AU3039589A (en) Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor
EP0313005A3 (en) Method for detecting carcinomatous and precarcinomatous colo-rectal disease
DE69027441D1 (en) Ribozymenhemmer
EP0233048A3 (en) Method of detecting urinary tract infection or inflammation
GB2062226A (en) Reagent and method for the determination of human-muscle aldolase
JPS57148253A (en) Quantitative kit for cancer resisting agent
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
ES2026274T3 (es) Procedimiento para obtener reactivos diagnosticos.
EP0241000A3 (en) Method for determination of complements
JPS57163319A (en) Preparation of antibody
JPS5797450A (en) Measuring method for enzyme immunity by competitive combination method of hormone using regenerable immune adsorption body

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment